Pharmaceutical composition for treating respiratory viral diseases

Abstract

The invention discloses a pharmaceutical composition for treating respiratory viral diseases. The traditional Chinese medicine composition is prepared from the following raw material components in parts by weight: 2-5 parts of tea velvet, 1-3 parts of semen armeniacae amarae, 4-7 parts of radix stemonae, 1-3 parts of fructus mume, 3-5 parts of bamboo shoot, 3-7 parts of herba ainsliaeae japonicae, 4-8 parts of herba artemisiae annuae powder, 2-4 parts of herba lysimachiae procumbens, 4-7 parts of herba melastomachiae, 5-9 parts of rhizoma chuanxiong, 1-3 parts of rutin, 1-3 parts of herba menthae, 2-4 parts of radix glycyrrhizae and 3-5 parts of kaempferol. The medicine is prepared from the medicinal materials such as tea velvet, semen armeniacae amarae, radix stemonae, fructus mume, bamboo shoot, ainsliaea crenata, artemisia apiacea powder, wild centella asiatica, berberis amurensis, ligusticum wallichii, rutin, mint, liquorice and kaempferol, so that the medicine can be used for quickly and effectively treating respiratory diseases, and meanwhile, the medicine is strong in antibacterial effect, quick in bacteriostasis and sterilization, not easy to generate drug resistance and free of toxic and side effects. Therefore, the treatment efficiency of respiratory diseases is effectively improved.

Description

Technical Field

[0001] The present invention relates to the technical field of respiratory disease medication, and in particular to a pharmaceutical composition for treating respiratory viral diseases. Background Art

[0002] Respiratory viral diseases are respiratory infectious diseases caused by viruses. Common diseases include colds and flu, which are usually transmitted through droplet transmission, direct contact and air transmission. The symptoms of these diseases include but are not limited to high fever, headache, cough, nasal congestion, sore throat, muscle aches, etc.

[0003] Common respiratory viral diseases include: Influenza: Also known as flu, it is an acute respiratory infectious disease caused by influenza virus. Influenza viruses are divided into three types: A, B, and C. Among them, influenza A and B viruses are the most common types of human infection. Common cold: A mild upper respiratory tract infection caused by a variety of viruses. Common viruses that cause common colds include rhinovirus, coronavirus, and adenovirus. Patients will have symptoms such as nasal congestion, itchy throat, and sneezing.

[0004] Herpangina: When Coxsackievirus A infects the tonsils or pharynx, it causes blisters to form on the surface. The color is grayish white, and there will be a red halo around the blisters due to mucosal congestion and edema. Viral pharyngitis: Adenovirus, influenza virus, etc. invade the pharynx, which may cause viral pharyngitis. The pharyngeal mucosa is congested and edematous, and may be accompanied by symptoms such as itchy throat, mild pain, and burning sensation. Pharyngoconjunctival fever: Coxsackievirus and adenovirus infections can also cause pharyngoconjunctival fever. The patient's pharynx and conjunctiva will have obvious congestion, which may cause symptoms such as sore throat and fever. For the treatment of respiratory viral diseases, antiviral drugs are usually required. For example, influenza virus infection can be treated with oseltamivir phosphate.

[0005] However, the existing drugs for respiratory diseases are relatively simple and cannot treat respiratory diseases quickly and effectively, thus affecting the treatment efficiency of respiratory diseases. Summary of the invention

[0006] 1. Technical problems to be solved

[0007] The purpose of the present invention is to solve the problem that the drugs for respiratory diseases in the prior art are relatively simple and cannot treat respiratory diseases quickly and effectively, and to propose a pharmaceutical composition for treating respiratory viral diseases.

[0008] 2. Technical solution

[0009] In order to achieve the above object, the present invention adopts the following technical solutions:

[0010] The pharmaceutical composition for treating respiratory viral diseases comprises the following raw materials in parts by weight: 2-5 parts of tea velvet, 1-3 parts of bitter almonds, 4-7 parts of stemonae, 1-3 parts of black plums, 3-5 parts of hairy shoots, 3-7 parts of tuerfeng, 4-8 parts of artemisia annua powder, 2-4 parts of wild horseshoe grass, 4-7 parts of yellow gentian, 5-9 parts of chuanxiong, 1-3 parts of rutin, 1-3 parts of mint, 2-4 parts of liquorice and 3-5 parts of kaempferol.

[0011] Preferably, the raw material components are calculated by weight as follows: 2 parts of tea velvet, 3 parts of bitter almonds, 4 parts of stemona, 3 parts of black plums, 3 parts of hairy shoots, 7 parts of scutellaria, 4 parts of artemisia annua powder, 4 parts of wild horseshoe grass, 4 parts of yellow flower grass, 9 parts of chuanxiong, 1 part of rutin, 3 parts of mint, 2 parts of licorice and 5 parts of kaempferol.

[0012] Preferably, the raw material components are calculated by weight as follows: 5 parts of tea velvet, 1 part of bitter almond, 7 parts of stemona, 1 part of ebony, 5 parts of hairy bamboo shoots, 3 parts of tuerfeng, 8 parts of artemisia annua, 2 parts of wild horseshoe grass, 7 parts of yellow lily, 5 parts of chuanxiong, 3 parts of rutin, 1 part of mint, 4 parts of licorice and 3 parts of kaempferol.

[0013] Preferably, the raw material components are calculated by weight as follows: 3 parts of tea velvet, 2 parts of bitter almonds, 5 parts of stemona, 2 parts of black plums, 4 parts of hairy shoots, 6 parts of scutellaria, 5 parts of artemisia annua powder, 3 parts of wild horseshoe grass, 6 parts of yellow flowers, 7 parts of chuanxiong, 2 parts of rutin, 2 parts of mint, 3 parts of licorice and 4 parts of kaempferol.

[0014] The present invention also proposes a method for preparing a pharmaceutical composition for treating respiratory viral diseases, which is characterized by comprising the following steps:

[0015] S1: Mix tea velvet, bitter almond, stemona, ebony, hairy bamboo shoot, tuerfeng, artemisia annua powder, wild horseshoe grass, yellow flower grass, chuanxiong, rutin, mint, liquorice and kaempferol according to certain weight parts, and then grind them into coarse powder in a grinder and sieve them to obtain a mixture;

[0016] S2: adding a certain amount of water to the mixture, steaming, and then feeding the mixture into a grinder to grind it into a mixed liquid;

[0017] S3: adding a certain amount of clean water to the mixed solution, boiling the mixture, and then performing ultrasonic treatment for 25-35 seconds to obtain a composite material.

[0018] Preferably, the coarse powder in S1 is sieved through a 45-60 mesh sieve.

[0019] Preferably, the cooking temperature in S2 is 70-80° C. and the cooking time is 15-25 min.

[0020] Preferably, the boiling temperature in S3 is 150-180° C. and the boiling time is 40-60 min.

[0021] Preferably, the amount of clean water in S2 and S3 is 2-4 times that of the mixed material and the mixed liquid.

[0022] 3. Beneficial effects

[0023] Compared with the prior art, the advantages of the present invention are:

[0024] In the present invention, by using tea velvet, bitter almond, stemona, black plum, hairy bamboo shoots, tuerfeng, artemisia annua powder, wild horseshoe grass, yellow general flower grass, chuanxiong, rutin, mint, licorice and kaempferol and other medicinal materials to prepare the medicine, the medicine can quickly and effectively treat respiratory diseases. At the same time, the medicine has a strong antibacterial effect, rapid antibacterial and killing, and is not easy to produce drug resistance, thereby effectively improving the treatment efficiency of respiratory diseases. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 The present invention is a schematic diagram of the preparation process of the pharmaceutical composition for treating respiratory viral diseases. DETAILED DESCRIPTION

[0026] The technical solutions in the embodiments of the present invention will be described clearly and completely below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments.

[0027] Embodiment 1:

[0028] The pharmaceutical composition for treating respiratory viral diseases comprises the following raw materials in parts by weight: 2-5 parts of tea velvet, 1-3 parts of bitter almonds, 4-7 parts of stemonae, 1-3 parts of black plums, 3-5 parts of hairy shoots, 3-7 parts of tuerfeng, 4-8 parts of artemisia annua powder, 2-4 parts of wild horseshoe grass, 4-7 parts of yellow gentian, 5-9 parts of chuanxiong, 1-3 parts of rutin, 1-3 parts of mint, 2-4 parts of liquorice and 3-5 parts of kaempferol.

[0029] In the present invention, reference is made to Figure 1 , a method for preparing a pharmaceutical composition for treating respiratory viral diseases, characterized in that it comprises the following steps:

[0030] S1: Mix tea velvet, bitter almond, stemona, ebony, hairy bamboo shoot, tuerfeng, artemisia annua powder, wild horsetail grass, yellow flower grass, chuanxiong, rutin, mint, liquorice and kaempferol according to certain weight parts, and then grind them into coarse powder in a grinder and sieve them, and the coarse powder is sieved through a 45-60 mesh sieve to obtain a mixture;

[0031] S2: Add 2-4 times of clean water to the mixture and steam it at a temperature of 70-80°C for 15-25 minutes, and then feed the mixture into a grinder and grind it into a mixed liquid;

[0032] S3: adding 2-4 times of clean water to the mixed solution, and then boiling at a temperature of 150-180° C. for 40-60 min. After boiling, ultrasonic treatment is performed for 25-35 s to obtain a composition.

[0033] In the present invention, by using tea velvet, bitter almond, stemona, black plum, hairy bamboo shoots, tuerfeng, artemisia annua powder, wild horseshoe grass, yellow general flower grass, chuanxiong, rutin, mint, licorice and kaempferol and other medicinal materials to prepare the medicine, the medicine can quickly and effectively treat respiratory diseases. At the same time, the medicine has a strong antibacterial effect, rapid antibacterial and killing, and is not easy to produce drug resistance, thereby effectively improving the treatment efficiency of respiratory diseases.

[0034] Embodiment 2:

[0035] It has the implementation content of the above-mentioned embodiment, wherein the specific implementation of the above-mentioned embodiment can refer to the above description, and the embodiment here will not be repeated in detail; and in the embodiment of the present application, it is different from the above-mentioned embodiment in that:

[0036] The pharmaceutical composition for treating respiratory viral diseases comprises the following raw materials in parts by weight: 2 parts of tea velvet, 3 parts of bitter almonds, 4 parts of stemona, 3 parts of black plums, 3 parts of hairy shoots, 7 parts of tuerfeng, 4 parts of artemisia annua powder, 4 parts of wild horseshoe grass, 4 parts of yellow lily, 9 parts of chuanxiong, 1 part of rutin, 3 parts of mint, 2 parts of liquorice and 5 parts of kaempferol.

[0037] Embodiment 3:

[0038] It has the implementation content of the above-mentioned embodiment, wherein the specific implementation of the above-mentioned embodiment can refer to the above description, and the embodiment here will not be repeated in detail; and in the embodiment of the present application, it is different from the above-mentioned embodiment in that:

[0039] The pharmaceutical composition for treating respiratory viral diseases comprises the following raw materials in parts by weight: 5 parts of tea velvet, 1 part of bitter almond, 7 parts of stemona, 1 part of black plum, 5 parts of hairy shoots, 3 parts of tuerfeng, 8 parts of artemisia annua, 2 parts of wild horseshoe grass, 7 parts of yellow lily, 5 parts of chuanxiong, 3 parts of rutin, 1 part of mint, 4 parts of liquorice and 3 parts of kaempferol.

[0040] Embodiment 4:

[0041] It has the implementation content of the above-mentioned embodiment, wherein the specific implementation of the above-mentioned embodiment can refer to the above description, and the embodiment here will not be repeated in detail; and in the embodiment of the present application, it is different from the above-mentioned embodiment in that:

[0042] The pharmaceutical composition for treating respiratory viral diseases comprises the following raw materials in parts by weight: 3 parts of tea velvet, 2 parts of bitter almonds, 5 parts of stemona, 2 parts of black plums, 4 parts of hairy shoots, 6 parts of smilax glabra, 5 parts of artemisia annua powder, 3 parts of wild horseshoe grass, 6 parts of yellow gentian, 7 parts of chuanxiong, 2 parts of rutin, 2 parts of mint, 3 parts of liquorice and 4 parts of kaempferol.

[0043] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.

Claims

1. A pharmaceutical composition for treating respiratory viral diseases, It is characterized in that The raw material components are calculated by weight as follows: 2-5 parts of tea velvet, 1-3 parts of bitter almonds, 4-7 parts of stemonae, 1-3 parts of black plums, 3-5 parts of hairy bamboo shoots, 3-7 parts of tuerfeng, 4-8 parts of artemisia annua powder, 2-4 parts of wild horseshoe grass, 4-7 parts of yellow flower grass, 5-9 parts of chuanxiong, 1-3 parts of rutin, 1-3 parts of mint, 2-4 parts of liquorice and 3-5 parts of kaempferol.

2. The pharmaceutical composition for treating respiratory viral diseases according to claim 1, It is characterized in that The raw material components are calculated by weight as follows: 2 parts of tea velvet, 3 parts of bitter almonds, 4 parts of stemonae, 3 parts of black plums, 3 parts of hairy shoots, 7 parts of scutellariae, 4 parts of artemisia annua powder, 4 parts of wild horseshoe grass, 4 parts of yellow flower grass, 9 parts of chuanxiong, 1 part of rutin, 3 parts of mint, 2 parts of liquorice and 5 parts of kaempferol.

3. The pharmaceutical composition for treating respiratory viral diseases according to claim 1, It is characterized in that The raw material components are calculated by weight as follows: 5 parts of tea velvet, 1 part of bitter almond, 7 parts of stemona, 1 part of black plum, 5 parts of hairy bamboo shoots, 3 parts of tuerfeng, 8 parts of artemisia annua, 2 parts of wild horseshoe grass, 7 parts of yellow flower grass, 5 parts of chuanxiong, 3 parts of rutin, 1 part of mint, 4 parts of liquorice and 3 parts of kaempferol.

4. The pharmaceutical composition for treating respiratory viral diseases according to claim 1, It is characterized in that The raw material components are calculated by weight as follows: 3 parts of tea velvet, 2 parts of bitter almonds, 5 parts of stemona, 2 parts of black plums, 4 parts of hairy shoots, 6 parts of scutellaria, 5 parts of artemisia annua powder, 3 parts of wild horseshoe grass, 6 parts of yellow flowers, 7 parts of chuanxiong, 2 parts of rutin, 2 parts of mint, 3 parts of liquorice and 4 parts of kaempferol.

5. A method for preparing a pharmaceutical composition for treating respiratory viral diseases according to any one of claims 1 to 4, It is characterized in that The following steps are involved: S1: Mix tea velvet, bitter almond, stemona, ebony, hairy bamboo shoot, tuerfeng, artemisia annua powder, wild horseshoe grass, yellow flower grass, chuanxiong, rutin, mint, liquorice and kaempferol according to certain weight parts, and then grind them into coarse powder in a grinder and sieve them to obtain a mixture; S2: adding a certain amount of water to the mixture, steaming, and then feeding the mixture into a grinder to grind it into a mixed liquid; S3: adding a certain amount of clean water to the mixed solution, boiling the mixture, and then performing ultrasonic treatment for 25-35 seconds to obtain a composite material.

6. The method for preparing the pharmaceutical composition for treating respiratory viral diseases according to claim 5, It is characterized in that The coarse powder in S1 is sieved through a 45-60 mesh sieve.

7. The method for preparing the pharmaceutical composition for treating respiratory viral diseases according to claim 5, It is characterized in that The cooking temperature in S2 is 70-80° C. and the cooking time is 15-25 min.

8. The method for preparing the pharmaceutical composition for treating respiratory viral diseases according to claim 5, It is characterized in that The boiling temperature in S3 is 150-180° C. and the boiling time is 40-60 min.

9. The method for preparing the pharmaceutical composition for treating respiratory viral diseases according to claim 5, It is characterized in that The amount of clean water in S2 and S3 is 2-4 times that of the mixed material and the mixed liquid.

Images